Dupilumab Is Effective in Treating EoE in Patients Weighing 15 Kg and above: Results from the Phase 3 KIDS Study

Mirna Chehade, Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Salvatore Oliva, Maternal and Child Health Department, Pediatric Gastroenterology and Liver Unit, Sapienza – University of Rome, Rome, Lazio, Italy; Antonella Cianferoni, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Karam Salama, Regeneron Inc, Corona, CA, United States; Changming Xia, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States; Sherif Zaghloul, Sanofi, Cambridge, MA, United States; Bram Raphael, Regeneron, Sleepy Hollow, NY, United States; Amr Radwan, Regeneron, Tarrytown, NY, United States; James Angello, Sanofi, Bridgewater, NJ, United States